Related Experiment Video
Updated: May 24, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis
Marco Trerotola1, Jing Li, Saverio Alberti
1Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Abstract:
Trop-2 is a transmembrane glycoprotein upregulated in several human carcinomas, including prostate cancer (PrCa). Trop-2 has been suggested to regulate cell-cell adhesion, given its high homology with the other member of the Trop family, Trop-1/EpCAM, and its ability to bind the tight junction proteins claudin-1 and claudin-7. However, a role for Trop-2 in cell adhesion to the extracellular matrix has never been postulated. Here, we show for the first time that Trop-2 expression in PrCa cells correlates with their aggressiveness. Using either shRNA-mediated silencing of Trop-2 in cells that endogenously express it, or ectopic expression of Trop-2 in cells that do not express it, we show that Trop-2 inhibits PrCa cell adhesion to fibronectin (FN). In contrast, expression of another transmembrane receptor, α(v) β(5) integrin, does not affect cell adhesion to this ligand. We find that Trop-2 does not modulate either protein or activation levels of the prominent FN receptors, β(1) integrins, but acts through increasing β(1) association with the adaptor molecule RACK1 and redistribution of RACK1 to the cell membrane. As a result of Trop-2 expression, we also observe activation of Src and FAK, known to occur upon β(1) -RACK1 interaction. These enhanced Src and FAK activities are not mediated by changes in either the activity of IGF-IR, which is known to bind RACK1, or IGF-IR's ability to associate with β(1) integrins. In summary, our data demonstrate that the transmembrane receptor Trop-2 is a regulator of PrCa cell adhesion to FN through activation of the β(1) integrin-RACK1-FAK-Src signaling axis.
Insights
Trop-2, a protein found in prostate cancer (PrCa), regulates cell adhesion to fibronectin by activating the β(1) integrin-RACK1-FAK-Src pathway, impacting cancer aggressiveness.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Trop-2 is a transmembrane glycoprotein often overexpressed in human carcinomas, including prostate cancer (PrCa).
- While Trop-2's role in cell-cell adhesion is suggested by homology to Trop-1/EpCAM and binding to tight junction proteins, its function in extracellular matrix adhesion is unexplored.
- PrCa aggressiveness is a critical factor in patient outcomes.
Purpose of the Study:
- To investigate the role of Trop-2 in prostate cancer cell adhesion to the extracellular matrix.
- To elucidate the molecular mechanisms by which Trop-2 influences cell adhesion and signaling pathways.
Main Methods:
- Trop-2 expression was manipulated using shRNA-mediated silencing and ectopic expression in PrCa cell lines.
- Cell adhesion assays were performed using fibronectin (FN) as the extracellular matrix ligand.
- Western blotting and co-immunoprecipitation were used to analyze protein interactions and signaling pathway activation (β(1) integrins, RACK1, Src, FAK, IGF-IR).
Main Results:
- Trop-2 expression in PrCa cells correlates with increased cancer aggressiveness.
- Trop-2 expression inhibits PrCa cell adhesion to fibronectin, independent of α(v) β(5) integrin.
- Trop-2 enhances the association of β(1) integrins with RACK1, promoting RACK1's translocation to the cell membrane.
- Trop-2 activates Src and FAK signaling pathways via the β(1) integrin-RACK1 interaction, without involving IGF-IR.
Conclusions:
- Trop-2 acts as a novel regulator of prostate cancer cell adhesion to fibronectin.
- The mechanism involves the activation of the β(1) integrin-RACK1-FAK-Src signaling axis.
- Trop-2's role in modulating cell adhesion and signaling pathways contributes to prostate cancer aggressiveness.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Intracellular Signaling Affects Focal Adhesions
Some...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Cancer Cell Migration through Invadopodia
